Advertisement

Congenital Tumor of the Hand and Upper Limb

  • Jinghong Xu
  • Jialiang ChenEmail author
  • Qifang He
  • Liulong Zhu
  • Jianmin Yao
Chapter
Part of the Plastic and Reconstructive Surgery book series (PRS)

Abstract

The bone tumor is classified into two types: primary and secondary. The incidence of primary bone tumor is 2/100,000 to 3/100,000, accounting for about 2% of all the tumors, and it can also be classified into tumor-like lesions, benign type and malignant type. The primary bone tumor is uncommon during the childhood; the commonest type is osteochondroma, followed by chondroma, osteoma, and ossifying fibroma. Generally, osteochondroma grows and becomes large within the initial 10 years, and the development process will end due to the closure of growth plates during the puberty. Generally, it takes a pedicled shape or wide basal shape, the difference in size is great, it is located at the endochondral bone of the long bone, it is commoner in the lower limb bones than in the upper limb bones, and there is a tendency of symmetric occurrence. It is the commonest at the lowest segment of the femur and the upper end of the tibia, followed by the upper end of the humeral bone, the lower end of the radial bone, the lower end of the tibia, and the upper end of the calf bone, it rarely occurs at the short bones and the irregular bones, the occurrence is occasionally seen in the spinal column, spinous process is often involved, and sometimes it can be complicated by other limb deformities. During the first onset, the pediatric patient generally shows no obvious symptoms, so it is often found during the childhood and puberty. Most of the patients visit a doctor due to deformities, hard painless tumor is palpable locally or in multiple sites, and when the tumor squeezes the surrounding nerves and vessels, pain and joint movement disorder can be induced.

References

  1. 1.
    Schmale GA, Conrad EU, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 1994;76:986–92.CrossRefPubMedGoogle Scholar
  2. 2.
    Legeai-Mallet L, Munnich A, Maroteaux P, Le Merrer M. Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet. 1997;52:12–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Stickens D, Clines G, Burbee D, Ramos P, Thomas S, Hogue D, Hecht JT, Lovett M, Evans GA. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet. 1996;14:25–32. doi: 10.1038/ng0996-25.CrossRefPubMedGoogle Scholar
  4. 4.
    Raskind WH, Conrad EU III, Matsushita M, Wijsman EM, Wells DE, Chapman N, Sandell LJ, Wagner M, Houck J. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses. Hum Mutat. 1998;11:231–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Legeai-Mallet L, Margaritte-Jeannin P, Lemdani M, Le Merrer M, Plauchu H, Maroteaux P, Munnich A, Clerget-Darpoux F. An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses. Hum Genet. 1997;99:298–302.CrossRefPubMedGoogle Scholar
  6. 6.
    Jager M, Westhoff B, Portier S, Leube B, Hardt K, Royer-Pokora B, Gossheger G, Krauspe R. Clinical outcome and genotype in patients with hereditary multiple exostoses. J Orthop Res. 2007;25:1541–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Vogel T, Skuban T, Kirchhoff C, et al. Dysplasia epiphysealis hemimelica of the distal ulna: a case report and review of the literature. Eur J Med Res. 2009;14:272–6.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Rao SB, Roy DR. Dysplasia epiphysealis hemimelica. Upper limb involvement with associated osteochondroma. Clin Orthop Relat Res. 1994;307:103–9.Google Scholar
  9. 9.
    Shapiro F, Simon S, Melvin J. Hereditary multiple exostoses. J Bone Joint Surg. 1979;61:815–23.CrossRefPubMedGoogle Scholar
  10. 10.
    Ehrenfried A. Multiple cartilaginous exostoses—hereditary deforming chondrodysplasia. A brief report on a little known disease. J Am Med Assoc. 1915;64:1642–6.CrossRefGoogle Scholar
  11. 11.
    Khoo RN, Peh WCG, Guglielmi G. Clinics in diagnostic imaging (124). Singapore Med J. 2008;49(10):841–5.PubMedGoogle Scholar
  12. 12.
    Casal D, Mavioso C, Mendes M-M, et al. Hand involvement in Ollier disease and Maffucci syndrome: a case series. Acta Reumatol Port. 2010;35:375–8.PubMedGoogle Scholar
  13. 13.
    D’Angelo L, Massimi L, Narducci A, et al. Ollier disease. Childs Nerv Syst. 2009;25:647–53.CrossRefPubMedGoogle Scholar
  14. 14.
    Costa J, Bogas M, Ribeiro A, et al. Multiple enchondromatosis: Ollier’s disease. Acta Reumatol Port. 2008;33:473–4.PubMedGoogle Scholar
  15. 15.
    Lewis RJ, Ketcham AS. Maffucci’s syndrome: functional and neoplastic significance. Case report and review of the literature. J Bone Joint Surg Am. 1973;55:1465–79.CrossRefPubMedGoogle Scholar
  16. 16.
    Ribeiro C, Fernandes P, Reis FC. The Maffucci syndrome with axial bone lesions. A rare cause of low back pain. Acta Med Port. 1998;11:559–62.PubMedGoogle Scholar
  17. 17.
    Zwenneke Flach H, Ginai AZ, Wolter Oosterhuis J. Best cases from the AFIP. Maffucci syndrome: radiologic and pathologic findings. RadioGraphics. 2001;21:1311–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Wester U, Brandberg G, Larsson M, et al. Chondrodysplasia punctata (CDP) with features of the tibia-metacarpal type and maternal phenytoin treatment during pregnancy. Prenat Diagn. 2002;22:663–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Herman TE, Lee BCP, McAlister WH, et al. Brachytelephalangic chondrodysplasia punctata with marked cervical stenosis and cord compression: report of two cases. Pediatr Radiol. 2002;32:452–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Mayden Argo K, Toriello HV, Jelsema RD, et al. Prenatal findings in chondrodysplasia punctata, tibia-metacarpal type. Ultrasound Obstet Gynecol. 1996;8:354.CrossRefGoogle Scholar
  21. 21.
    Göllesa A, Stolzb P, Freyschmidtc J, et al. Trevor’s disease (dysplasia epiphysealis hemimelica) located at the hand: case report and review of the literature. Eur J Radiol. 2011;77:245–8.CrossRefGoogle Scholar
  22. 22.
    Hensinger RN, Cowell HR, Ramsey PL, et al. Familial dysplasia epiphysealis hemimelica, associated with chondromas and osteochondromas. J Bone Joint Surg. 1974;56:1513–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Oestreich AE, Mitchell CS, Akeson JW. Both Trevor and Ollier disease limited to one upper extremity. Skelet Radiol. 2002;31:230–4.CrossRefGoogle Scholar
  24. 24.
    DiCaprio MR, Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87(8):1848–68.PubMedGoogle Scholar
  25. 25.
    Kokkalis ZT, Jain S, Sotereanos DG. Fibrous dysplasia around the elbow. J Shoulder Elb Surg. 2010;19:e6–11.CrossRefGoogle Scholar
  26. 26.
    McCaffrey M, Letts M, Carpenter B. Osteofibrous dysplasia: a review of the literature and presentation of an additional 3 cases. Am J Orthop. 2003;32(10):479–86.PubMedGoogle Scholar
  27. 27.
    Sakamoto A, Oda Y, Iwamoto Y, et al. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to GSa mutation at the Arg201 codon. J Mol Diagn. 2000;2:67–72.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Takaku M, Hashimoto I, Nakanishi H, et al. Calcifying aponeurotic fibroma of the elbow: a case report. J Med Investig. 2011;58:159–61.CrossRefGoogle Scholar
  29. 29.
    Kramer JM, Doscher JC, Ruvinsky M. Calcifying aponeurotic fibroma with bone islands exhibiting hematopoiesis: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:878–82.CrossRefPubMedGoogle Scholar
  30. 30.
    Robbin MR, Murphey MD, Thomas Temple H, et al. Imaging of musculoskeletal fibromatosis. RadioGraphics. 2001;21:585–600.CrossRefPubMedGoogle Scholar
  31. 31.
    Onak-Kandemir N, Ege-Gul A, Karadayi N. Calcifying aponeurotic fibroma: a case report. Acta Orthop Traumatol Turc. 2008;42(2):145–7.PubMedGoogle Scholar
  32. 32.
    Keasbey LE. Juvenile aponeurotic fibroma (calcifying fibroma). A distinctive tumor arising in the palms and soles of young children. Cancer. 1953;6:338.CrossRefPubMedGoogle Scholar
  33. 33.
    Morii T, Yoshiyama A, Morioka H, et al. Clinical significance of magnetic resonance imaging in the preoperative differential diagnosis of calcifying aponeurotic fibroma. J Orthop Sci. 2008;13:180–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Song YS, Lee IS, Kim HT, et al. Fibrous hamartoma of infancy in the hand: unusual location and MR imaging findings. Skelet Radiol. 2010;39:1035–8.CrossRefGoogle Scholar
  35. 35.
    Seguier-Lipszyc E, Hermann G, Kaplinski C, et al. Fibrous hamartoma of infancy. J Pediatr Surg. 2011;46:753–5.CrossRefPubMedGoogle Scholar
  36. 36.
    Kang G, Suh Y-L, Han J, et al. Fibrous hamartoma of infancy: an experience of a single institute. J Korean Surg Soc. 2011;81:61–5.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    McGowan J IV, Smith CD, Maize J Jr, et al. Giant fibrous hamartoma of infancy: a report of two cases and review of the literature. J Am Acad Dermatol. 2011;64:579–86.CrossRefPubMedGoogle Scholar
  38. 38.
    Wang W. Plastic surgery science. Hangzhou: Zhejiang Science and Technology Press; 1999. p. 460–1.Google Scholar
  39. 39.
    Sorensen SA, Mulvihill JJ, Nielsen A, et al. Long-term follow-up of von Recklinghausen neurofibromatosis. N Engl J Med. 1986;314:1010–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Riccardi V. von Recklinghausen neurofibromatosis. N Engl J Med. 1981;305:1617–27.CrossRefPubMedGoogle Scholar
  41. 41.
    Wallace MR, Marchuk DA, Anderson LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990;249:181–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Mulvihill JJ. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med. 1900;113:39–52.CrossRefGoogle Scholar
  43. 43.
    Gutmann DH, Collins FS. Recent progress toward understanding the molecular biology of von Recklinghausen neurofibromatosis. Ann Neurol. 1992;31(5):555–61.CrossRefPubMedGoogle Scholar
  44. 44.
    Pollack IF, Mulvihill JJ. Neurofibromatosis 1 and 2. Brain Pathol. 1997;7:823–36.CrossRefPubMedGoogle Scholar
  45. 45.
    Morris JA, Shochat S, Smith EI, et al. Biological variables in thoracic neuroblastoma: a Pediatric Oncology Group Study. J Pediatr Surg. 1995;30:296–303.CrossRefPubMedGoogle Scholar
  46. 46.
    Franks LM, Bollen A, Seeger RC, et al. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer. 1997;79:2028–35.CrossRefPubMedGoogle Scholar
  47. 47.
    Cotterill SJ, Pearson AD, Prichard J, et al. Clinical prognostic factors in 1277 patients with neuroblastoma: results of the European Neuroblastoma Study Group Survey 1982-1992. Eur J Cancer. 2000;36:901–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and Zhejiang Science and Technology Publishing House 2017

Authors and Affiliations

  • Jinghong Xu
    • 1
  • Jialiang Chen
    • 1
    Email author
  • Qifang He
    • 2
  • Liulong Zhu
    • 2
  • Jianmin Yao
    • 3
  1. 1.Department of Plastic Surgery, The First Affiliated Hospital, Zhejiang UniversityHangzhouChina
  2. 2.Hangzhou City First People’s HospitalHangzhouChina
  3. 3.Hangzhou Plastic Surgery HospitalHangzhouChina

Personalised recommendations